Fundraising FoxPandect Bioventures
Venture capitalWoodside · Seed–Late Stage · 10 people tracked
Find your way into Pandect Bioventures
Each arrow is one introduction. Sign up to fill in the first one.
Ask David Schaffer to introduce you to Walter H. Moos
You →David · together at Valitor →Walter
Sign up to find every way you can get introduced to Pandect Bioventures
- Your email: who you already know at Pandect Bioventures, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pandect Bioventures team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Pandect Bioventures focuses on transformational healthcare and life science opportunities at the earliest stage. It leverages an ecosystem of a 40,000 square foot incubator facility, exclusive relationships with research institutions, and experienced academic and industry advisors to source and grow investments. Executives-in-residence and management bring decades of operating experience to portfolio companies. Opportunities are evaluated through a rigorous assessment process, with funding spanning seed, Series A, and later rounds. The firm frequently co-invests alongside other life science investors and forms new companies with academic co-founders drawn from leading research institutions.
Source: firm website, verified Sep 29, 2026.
Team · 10 people
from the firm's website & public directories
What they invest in
from 5 of 5 portfolio companiesBiotech ×5Medical Devices ×5Healthtech ×2AI & Machine Learning ×1Deep Tech ×1Digital Health ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
Circle Pharma develops cancer treatments using macrocycle therapies designed to reduce side effects compared to conventional therapies.
BiotechDigital HealthHealthtechMedical DevicesSouth San Francisco, US
Matthew P. Jacobson(Co-founder)Scott R. Lokey(Director)David J. Earp(President & CEO)inPaul Park(Executive Officer)
BoardThilo Schroeder(Director)in
Board seatWalter H. Moos· per SEC Form D
Co-investorsBerkeley CatalystHemisphere Ventures LLCJude GomilaLifeforce CapitalMission Bay CapitalMission Biocapital+3 more
Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases.
BiotechDeep TechMedical DevicesSouth San Francisco, US
Alan Ashworth(Founder)Alan Ashworth, Ph.D., FRS(Scientific Founder)
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsAngel Physicians FundBerkeley CatalystExSight VenturesFirst Spark Ventures, LlcTaihill Venture
Walden Biosciences is a clinical-stage biotech company developing disease-modifying therapies that selectively target the kidney to treat the underlying drivers of kidney disease.
BiotechMedical Devices
Co-investorsARCH Venture PartnersATEM Capital FundUCB Ventures
Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.
AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US
Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)
Co-investorsFirst Spark Ventures, LlcIllumina VenturesNorthpond Ventures
Frequently asked questions
- How many investments has Pandect Bioventures made?
- Pandect Bioventures has 5 tracked investments.
- What stage does Pandect Bioventures invest at?
- Pandect Bioventures invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Pandect Bioventures focus on?
- Pandect Bioventures focuses on Biotech, Healthtech, Longevity, Medical Devices.
- Where is Pandect Bioventures located?
- Pandect Bioventures is headquartered in Woodside, US.
- Who does Pandect Bioventures co-invest with?
- Pandect Bioventures most often shares deals with Berkeley Catalyst, First Spark Ventures, Llc, ARCH Venture Partners, among 15 tracked co-investors.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
EQT Life Sciences (formerly LSP) is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally.
ARTIS Ventures is a venture capital firm investing in breakthrough companies at the convergence of technology and biology, with a focus on healthcare and life sciences ('TechBio'). It backs founders across biotech, therapeutics, digital health, and frontier technologies.
SV Health Investors is a global private equity and venture capital platform dedicated to healthcare, running specialized funds across biotechnology (including dementia), healthcare growth equity, and medtech.